Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [3]. - Investors have until February 9, 2026, to request to lead the case [3]. Group 2: Company Performance and Allegations - Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices [4]. - The company allegedly overstated demand for its electrophysiology devices while public assurances contradicted the actual decline in demand and revenue [5]. - On October 23, 2025, Integer lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, down from a previous range of $1.850 billion to $1.876 billion, which was below analysts' expectations [6]. Group 3: Stock Impact - Following the announcement of lowered sales guidance, Integer's stock price dropped by $35.22 per share, a decline of over 32%, from $109.11 on October 22, 2025, to $73.89 on October 23, 2025 [6].

Core Points - A class action lawsuit has been filed against CoreWeave, Inc. and certain senior executives for securities fraud following significant stock drops due to potential violations of federal securities laws [1][3] - Investors are encouraged to seek additional information regarding the lawsuit and their legal options [2][9] Company Overview - CoreWeave is an AI-focused cloud computing company that operates data centers providing high-performance GPU infrastructure [4] - The company relies on partnerships, including a merger agreement with Core Scientific announced on July 7, 2025 [4] Allegations and Stock Performance - CoreWeave allegedly overstated its ability to meet customer demand and concealed significant construction delays at its data centers [5] - The stock price dropped significantly due to various announcements: - On October 30, 2025, the stock fell by $8.87 (over 6%) after Core Scientific failed to secure enough shareholder votes for the merger [6] - On November 10, 2025, the stock dropped by $17.22 (over 16%) following a lowered guidance for revenue and operational metrics due to construction delays [7] - On December 15, 2025, the stock decreased by $2.85 (over 3%) after reports of further delays in a major data center project [8]

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance and Stock Impact - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the release of Q3 2025 financial results on November 20, 2025, which included a further reduction in full-year guidance and acknowledgment that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Proceedings - Investors have until March 13, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in the U.S. District Court for the Southern District of Ohio [3].

New York, New York--(Newsfile Corp. - January 15, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

Core Viewpoint - Investors in Varonis Systems, Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged misleading statements regarding the company's ability to sustain its annual recurring revenue (ARR) growth trajectory [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that from February 4, 2025, to October 28, 2025, Varonis failed to disclose its inability to maintain a high rate of quarterly conversions necessary for continued ARR growth [2]. - Defendants' positive statements about Varonis' business operations and prospects were claimed to be materially misleading and lacked a reasonable basis during the relevant period [2]. Group 2: Participation Information - Investors who suffered losses related to Varonis Systems, Inc. are encouraged to participate in the ongoing securities fraud lawsuit, with a lead plaintiff deadline set for March 9, 2026 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate in the class action [3][4].

CoreWeave securities between March 28, 2025, and December 15, 2025, inclusive (the "Class Period†). The lead plaintiff deadline is March 13, 2026. The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) CoreWeave had overstated the company's ability to meet customer demand for its service; (2) CoreWeave materially understated the scope and severity of the risk that CoreWeave's reliance on a single third-party data cent ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURI ...

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CoreWeave securities between March 28, 2025 and December 15, 2025, both dat ...

Core Viewpoint - A securities class action lawsuit has been filed against Varonis Systems, Inc. for alleged investment losses incurred by investors who purchased or acquired Varonis common stock between February 4, 2025, and October 28, 2025 [1][6]. Group 1: Lawsuit Details - The lawsuit claims that Varonis made false and misleading statements and failed to disclose critical information regarding its ability to sustain its Annual Recurring Revenue (ARR) growth without maintaining a high rate of quarterly conversions [2]. - The lead plaintiff deadline for the lawsuit is set for March 9, 2026, allowing affected investors to seek representation [3][6]. Group 2: Legal Representation - Kessler Topaz Meltzer & Check, LLP is the law firm representing the class of investors and encourages those who suffered significant losses to contact them for more information [4][5]. - The firm has a strong reputation in securities-fraud class actions and has achieved notable recoveries in past litigations [5]. Group 3: Affected Investors - The class period for the lawsuit is defined as February 4, 2025, through October 28, 2025, during which investors are seeking recovery for material misstatements and omissions [6]. - Investors can choose to be appointed as lead plaintiffs or remain absent class members, with the ability to share in any recovery not affected by their decision [3].

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Five Below, Inc. [1] Group 1: Legal Actions and Shareholder Rights - Long-term shareholders of Five Below may seek corporate governance reforms, return of funds, financial incentive awards, or other benefits [2] - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees [2] Group 2: Importance of Shareholder Participation - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced transparency, accountability, and management effectiveness [3] Group 3: Firm's Background and Achievements - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]